influenza
virus
remain
frequent
identifi
caus
viral
infect
lung
respiratori
syncyti
viru
rsv
remain
major
caus
sever
pneumonia
children
worldwid
increasingli
recogn
caus
ill
adult
elderli
patient
agent
rhinoviru
rv
increasingli
detect
mirror
advanc
molecular
serolog
diagnost
techniqu
increas
surveil
program
nonetheless
divers
viral
agent
caus
pulmonari
diseas
extrem
broad
continu
expand
tabl
sever
newli
recogn
viral
pathogen
identifi
past
decad
among
fear
lethal
emerg
infect
includ
caus
hantavirus
nipah
viru
pandem
influenza
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
coronavirus
convers
certain
viral
infect
particularli
occur
vulner
patient
cohort
diminish
interv
exampl
us
incid
varicella
pneumonia
declin
sinc
univers
childhood
vaccin
varicella
implement
advanc
clinic
manag
transplant
recipi
reduc
incid
cytomegaloviru
cmv
pneumonia
chapter
captur
describ
select
viral
diseas
pulmonari
system
main
target
infect
although
import
note
viral
agent
detect
pulmonari
tissu
chikungunya
viru
west
nile
viru
rabi
viru
heartland
viru
typic
context
system
diseas
adenovirus
nonenvelop
doublestrand
dna
virus
repres
ubiquit
divers
group
least
serotyp
found
natur
upper
respiratori
tract
gastrointestin
system
human
mammal
bird
known
adenoviru
serotyp
associ
human
diseas
encompass
wide
rang
present
infect
target
wide
varieti
organ
system
other
rare
encount
may
may
caus
recogniz
diseas
estim
approxim
pneumonia
infant
young
children
caus
adenovirus
pediatr
case
adenoviru
pneumonia
occur
month
year
age
caus
serotyp
serotyp
particularli
pathogen
adenovirus
abil
result
dissemin
often
fatal
diseas
previous
healthi
children
major
infect
pediatr
popul
spontan
resolv
often
result
clinic
appar
ill
adult
pneumonia
gener
associ
serotyp
period
epidem
adenoviru
pneumonia
immunocompet
adult
identifi
reemerg
adenoviru
subtyp
associ
sever
diseas
militari
camp
hospit
school
unit
state
europ
asia
manner
similar
pathogen
adenovirus
take
advantag
impair
destroy
immun
system
establish
persist
dissemin
infect
immunocompromis
host
popul
suscept
broader
rang
differ
serotyp
adenovirus
establish
latenc
lymphoid
tissu
kidney
host
believ
mani
possibl
case
clinic
diseas
caus
adenovirus
immunocompromis
patient
reactiv
infect
chest
film
typic
show
bilater
multifoc
lobar
segment
consolid
bronchial
wall
thicken
hyperaer
lobar
atelectasi
pleural
effus
pneumatocel
report
less
frequent
lung
patient
adenoviru
pneumonia
heavi
edemat
area
consolid
hemorrhag
welldemarc
yellow
foci
repres
necrot
inflam
pulmonari
parenchyma
mucosa
larg
airway
gener
hemorrhag
congest
bronchi
fill
mucoid
fibrinopurul
exud
primari
histopatholog
find
includ
necrot
tracheobronch
bronchiol
extens
denud
epithelium
particularli
mediums
mm
diamet
intrapulmonari
bronchi
fig
affect
airway
may
occlud
homogen
eosinophil
materi
mix
inflammatori
cell
detach
epithelium
cellular
debri
lamina
propria
bronchi
bronchiol
typic
congest
infiltr
predominantli
mononuclear
inflammatori
cell
infiltr
tracheal
bronchial
serou
mucou
gland
also
often
involv
show
necrosi
mix
inflammatori
infiltr
fig
incid
n
approxim
pneumonia
infant
young
children
n
period
epidem
adenoviru
pneumonia
young
adult
occur
particularli
among
militari
recruit
n
immunocompromis
adult
especi
transplant
recipi
vulner
sever
sometim
fatal
pneumonia
caus
adenovirus
n
immunocompromis
patient
case
fatal
rate
adenovir
pneumonia
approach
versu
approxim
mortal
immunocompet
patient
n
immunocompromis
young
patient
develop
dissemin
diseas
n
oblit
bronchiol
potenti
caus
longterm
morbid
survivor
infect
sjm
rare
complic
gender
race
age
distribut
n
pediatr
case
adenoviru
pneumonia
occur
month
year
age
caus
serotyp
n
caus
sever
diseas
neonat
may
lead
longterm
complic
n
adult
pneumonia
gener
associ
serotyp
reemerg
serotyp
certain
cohort
n
recogn
gender
racial
predilect
clinic
featur
n
acut
upper
respiratori
tract
diseas
manifest
tracheobronch
n
adenoviru
pneumonia
present
sign
symptom
similar
type
pneumonia
includ
fever
cough
chest
pain
radiolog
featur
n
bilater
multifoc
lobar
segment
consolid
bronchial
wall
thicken
hyperaer
lobar
atelectasi
n
pleural
effus
pneumatocel
report
less
frequent
prognosi
therapi
n
proven
effect
antivir
therapi
n
patient
receiv
support
care
symptom
diseas
n
sever
infect
may
progress
death
week
familyag
viru
infect
progress
involv
distal
pulmonari
parenchyma
form
foci
bronchocentr
necrosi
hemorrhag
neutrophil
mononuclear
cell
infiltr
karyorrhexi
fig
find
occur
background
diffus
alveolar
damag
adenovirus
form
intranuclear
inclus
respiratori
epitheli
cell
trachea
bronchi
bronchiol
acinar
cell
bronchial
gland
alveolar
pneumocyt
gener
abund
viabl
edg
necrot
foci
hematoxylineosin
stain
earli
inclus
appear
small
dens
amphophil
structur
surround
clear
zone
peripher
margin
chromatin
similar
herpet
inclus
cellular
infect
progress
inclus
becom
larger
larg
micron
cell
basophil
margin
nuclear
membran
becom
blur
form
characterist
smudg
cell
fig
concurr
bacteri
fungal
viral
infect
common
variou
method
use
diagnos
adenoviru
infect
includ
antigen
detect
fluoresc
antibodi
assay
enzym
immunoassay
eia
cell
cultur
electron
microscopi
molecular
assay
serolog
test
groupspecif
typespecif
antibodi
immunohistochem
ihc
stain
method
detect
adenovirusinfect
cell
formalinfix
paraffinembed
tissu
use
variou
commerci
avail
adenoviru
groupspecif
antibodi
fig
electron
microscopi
adenovirusinfect
tissu
reveal
paracrystallin
array
virion
repres
icosahedr
capsid
measur
nm
diamet
fig
adenovirus
isol
cell
cultur
bronchial
wash
tracheal
aspir
lung
biopsi
specimen
earli
stage
ill
molecular
assay
particularli
gene
amplif
use
polymeras
chain
reaction
pcr
situ
hybrid
ish
method
develop
detect
adenoviru
nucleic
acid
respiratori
secret
formalinfix
paraffinembed
tissu
differenti
diagnosi
includ
agent
caus
necrot
bronchiol
pneumonia
intranuclear
viral
inclus
particularli
herp
simplex
virus
hsv
varicella
zoster
viru
vzv
cmv
histolog
clue
distinguish
agent
adenoviru
includ
presenc
hsv
vzv
absenc
adenoviru
multinucl
cell
cytoplasm
inclus
cmv
distinct
smudg
cell
adenoviru
howev
ancillari
studi
gener
requir
confirm
immunocompromis
patient
case
fatal
rate
adenovir
pneumonia
approach
compar
approxim
mortal
immunocompet
patient
proven
effect
antivir
therapi
adenoviru
infect
though
studi
report
posit
outcom
treatment
cidofovir
patient
receiv
support
care
symptom
diseas
includ
cessat
immunesuppress
drug
patient
iatrogen
immunosuppress
chronic
lung
diseas
bronchiectasi
organ
pneumonia
report
longterm
sequela
rare
complic
adenoviru
pneumoniapatholog
featur
gross
find
n
lung
typic
heavi
edemat
consolid
region
hemorrhag
n
bronchi
gener
fill
mucoid
fibrin
purul
exud
hemorrhag
congest
mucosa
n
necrot
inflammatori
foci
pulmonari
parenchyma
may
repres
palpabl
yellow
nodul
n
necrot
tracheobronch
bronchiol
extens
denud
surfac
epithelium
particularli
mediums
mm
diamet
bronchi
n
affect
airway
may
occlud
homogen
eosinophil
materi
mix
inflammatori
cell
detach
epithelium
cellular
debri
n
tracheal
bronchial
serou
mucou
gland
also
often
involv
show
necrosi
mix
inflammatori
infiltr
n
bronchocentr
parenchym
necrosi
hemorrhag
neutrophil
mononuclear
cell
infiltr
background
exud
diffus
alveolar
damag
n
intranuclear
inclus
respiratori
epitheli
cell
alveolar
pneumocyt
gener
abund
viabl
edg
necrot
foci
earli
inclus
appear
small
dens
amphophil
structur
surround
clear
zone
peripher
margin
chromatin
similar
herpet
inclus
matur
inclus
larger
basophil
margin
nuclear
membran
becom
blur
form
characterist
smudg
cell
occur
may
juli
primarili
southwestern
state
initi
symptom
hfr
hp
similar
resembl
seen
earli
phase
mani
viral
diseas
fever
myalgia
headach
vomit
weak
cough
common
symptom
earli
phase
hfr
hp
renal
involv
seen
case
hfr
clinic
present
rang
mild
ill
minim
renal
dysfunct
sever
form
acut
renal
failur
shock
hfr
patient
die
later
phase
renal
failur
typic
show
signific
pulmonari
edema
clinic
pictur
hp
quit
differ
hfr
initi
prodrom
follow
rapidli
progress
pulmonari
edema
respiratori
insuffici
shock
fatal
case
major
death
occur
within
day
hospit
hemorrhag
peripher
sign
vasomotor
instabl
flush
conjunctiv
inject
periorbit
edema
seen
hfr
extrem
rare
hematolog
featur
peripher
blood
smear
includ
neutrophil
without
signific
toxic
chang
myelocytosi
increas
circul
immunoblast
lymphocyt
thrombocytopenia
hemoconcentr
combin
acut
pulmonari
edema
suggest
presumpt
diagnosi
hantaviru
infect
definit
n
hantavir
diseas
caus
close
relat
triseg
negativesens
rna
virus
genu
hantaviru
famili
bunyavirida
n
two
class
hantavirusassoci
ill
describ
hfr
diseas
kidney
primarili
involv
hp
diseas
lung
primarili
affect
incid
locat
n
zoonot
virus
maintain
natur
asymptomat
infect
rodent
n
transmiss
human
usual
associ
exposur
rodent
around
home
perform
agricultur
activ
clean
anim
shed
sleep
ground
certain
occup
n
serotyp
distribut
throughout
world
n
hfr
common
europ
asia
wherea
hp
almost
exclus
seen
america
n
rare
caus
pneumonia
morbid
mortal
n
hfr
mortal
rate
rang
n
hp
mortal
rate
may
exceed
n
survivor
hfr
recoveri
usual
complet
longterm
sequela
gender
race
age
distribut
n
specif
gender
race
age
distribut
gener
seen
n
prodrom
fever
myalgia
headach
vomit
weak
cough
common
hfr
hp
n
renal
involv
seen
case
hfr
clinic
present
rang
mild
ill
minim
renal
dysfunct
sever
form
acut
renal
failur
shock
n
hp
prodrom
follow
rapidli
progress
pulmonari
edema
respiratori
insuffici
shock
n
interstiti
edema
without
consolid
major
case
within
hour
hospit
n
pleural
effus
common
prognosi
therapi
n
support
therapi
dialysi
circulatori
respiratori
support
n
ribavirin
effect
treatment
hfr
hp
gross
find
n
sever
hfr
gelatin
retroperiton
fluid
accumul
distinct
triad
hemorrhag
necrosi
junction
zone
renal
medulla
right
atrium
heart
anterior
pituitari
n
hp
larg
bilater
pleural
effus
heavi
edemat
lung
microscop
find
n
hfr
sever
characterist
microscop
lesion
involv
kidney
n
hp
lung
interstiti
pneumon
seen
case
character
edema
interstiti
mononuclear
cell
infiltr
variabl
hyalin
membran
diffus
alveolar
damag
chronic
extrapulmonari
immunoblast
spleen
lymph
node
peripher
blood
immunohistochem
featur
n
ihc
test
formalinfix
tissu
sensit
method
confirm
infect
n
hantavir
antigen
commonli
detect
endotheli
cell
involv
organ
hp
hfr
n
viru
particl
nm
diamet
gener
appear
spheric
oval
shape
n
lipid
envelop
contain
glycoprotein
spike
surround
core
consist
genom
nucleocapsid
arrang
delic
tangl
filament
n
granulofilament
viral
inclus
seen
endotheli
cell
n
viral
particl
extrem
difficult
visual
tissu
patholog
differenti
diagnosi
n
histopatholog
hematolog
find
suggest
diagnosi
hp
hfr
howev
laboratori
confirm
essenti
confirm
diagnosi
n
differenti
diagnosi
includ
larg
number
viral
rickettsi
bacteri
infect
well
noninfecti
diseas
chest
radiograph
may
normal
earli
cours
hp
evid
bilater
interstiti
edema
observ
major
case
within
hour
hospit
may
resembl
acut
respiratori
distress
syndrom
ard
larg
quantiti
proteinrich
gelatin
retroperiton
edema
fluid
found
hypotens
phase
sever
hfr
wherea
hp
patient
larg
bilater
pleural
effus
heavi
edemat
lung
fatal
far
eastern
hfr
distinct
triad
hemorrhag
necrosi
junction
zone
renal
medulla
right
atrium
heart
anterior
pituitari
seen
patient
hp
hemorrhag
exceedingli
rare
ischem
necrot
lesion
except
attribut
shock
seen
histolog
morpholog
chang
endothelium
uncommon
seen
consist
promin
swollen
endotheli
cell
vascular
thrombi
endotheli
cell
necrosi
rare
hfr
sever
characterist
microscop
lesion
involv
kidney
includ
microvascular
inflamm
medullari
interstiti
hemorrhag
acut
tubular
necrosi
howev
interstiti
pneumon
also
seen
fatal
case
contrast
microscop
chang
hp
princip
seen
lung
spleen
lung
show
mildtomoder
interstiti
pneumon
interstiti
mononuclear
cell
compos
mixtur
small
enlarg
mononuclear
cell
appear
immunoblast
variabl
degre
edema
fig
focal
hyalin
membran
compos
condens
proteinac
intraalveolar
edema
fluid
fibrin
variabl
number
inflammatori
cell
observ
typic
neutrophil
scant
alveolar
pneumocyt
intact
evid
cellular
debri
nuclear
fragment
hyperplasia
fatal
case
prolong
surviv
interv
tissu
show
featur
characterist
exud
prolif
stage
diffus
alveolar
damag
fig
characterist
microscop
find
hp
case
includ
variabl
number
immunoblast
within
splenic
red
pulp
periarteriolar
white
pulp
fig
lymph
nodal
paracort
zone
hepat
portal
triad
peripher
blood
virusspecif
diagnosi
confirm
achiev
serolog
pcr
hantaviru
rna
ihc
hantavir
antigen
serolog
test
detect
hantavirusspecif
immunoglobulin
rise
titer
immunoglobulin
g
patient
sera
consid
method
choic
laboratori
confirm
hp
pcr
detect
viral
rna
blood
tissu
extrem
use
diagnost
epidemiolog
purpos
hantavir
rna
also
detect
formalinfix
paraffinembed
archiv
tissu
revers
transcript
rt
pcr
ihc
test
formalinfix
tissu
sensit
method
confirm
hantavir
infect
viral
antigen
found
primarili
within
capillari
endothelium
throughout
variou
tissu
hp
hfr
fig
hp
mark
accumul
hantavir
antigen
found
pulmonari
microvasculatur
splenic
lymph
nodal
follicular
dendrit
cell
electron
microscop
studi
hp
lung
tissu
demonstr
infect
endotheli
cell
macrophag
viru
viruslik
particl
observ
infrequ
extrem
difficult
identifi
autopsi
tissu
contrast
typic
endotheli
granulofilament
inclus
seen
frequent
fig
hp
suspect
case
ard
without
known
precipit
caus
among
previous
healthi
individu
level
suspicion
particularli
high
patient
known
exposur
rodent
area
deer
mice
peromyscu
maniculatu
reservoir
hantaviru
found
physician
need
differenti
hp
common
acut
respiratori
diseas
pneumococc
pneumonia
influenza
viru
unexplain
ard
diseas
need
distinguish
patholog
hp
includ
rel
larg
number
differ
viral
rickettsi
bacteri
infect
well
variou
noninfecti
diseas
process
recoveri
hfr
usual
complet
appar
longterm
sequela
mortal
rate
hfr
rang
shock
uremia
main
contribut
caus
death
although
pulmonari
edema
implic
patient
one
studi
account
confirm
hp
case
unit
state
casefat
rate
though
mortal
rate
may
exceed
depend
serotyp
involv
though
similar
biochem
alter
occur
patient
lowest
thrombocytopenia
median
cellsml
well
increas
hematocrit
creatinin
level
leukocyt
count
occur
often
fatal
hp
case
need
supplementari
oxygen
intub
also
associ
poor
outcom
manag
patient
hp
hfr
often
complex
phase
specif
support
therapi
dialysi
circulatori
respiratori
support
basi
treatment
mer
first
detect
saudi
arabia
case
report
arabian
peninsula
numer
travelassoci
case
health
careassoci
outbreak
report
largest
republ
korea
anim
reservoir
sar
mer
uncertain
though
bat
suspect
play
role
appear
like
civet
cat
small
mammal
play
role
amplifi
host
within
anim
market
transmiss
sar
strong
evid
link
dromedari
camel
camelrel
product
transmiss
mer
human
sar
mer
caus
spectrum
ill
rang
asymptomat
infect
influenzalik
ill
typic
present
acut
onset
fever
myalgia
malais
chill
respiratori
failur
shock
multiorgan
failur
death
symptom
includ
sore
throat
nausea
vomit
diarrhea
infect
occur
peopl
age
sar
children
tend
much
milder
clinic
cours
adult
mer
sever
diseas
death
occur
frequent
patient
chronic
comorbid
estim
incub
period
day
transmiss
thought
primarili
occur
persontoperson
contact
particularli
respiratori
secret
radiolog
featur
sar
includ
peripher
appear
lung
opac
lower
lobe
predomin
mixtur
groundglass
opac
interstiti
thicken
bronchiectasi
pneumomediastinum
without
preced
positivepressur
ventil
intub
seen
later
diseas
multifoc
peripher
subpleur
groundglass
opacif
consolid
commonli
observ
comput
tomograph
ct
featur
time
diagnosi
patient
sar
mer
radiolog
featur
includ
progress
bilater
pulmonari
opac
includ
groundglass
alveolarinterstiti
infiltr
consolid
air
bronchogram
peripher
interstiti
infiltr
lower
lobe
consolid
ct
n
spread
primarili
person
person
cough
sneez
infect
person
n
estim
incub
period
day
n
uncompl
ill
influenzalik
ill
character
abrupt
onset
fever
myalgia
headach
malais
nonproduct
cough
sore
throat
rhiniti
n
peripher
lung
opac
lower
lobe
predomin
mixtur
groundglass
opac
interstiti
thicken
bronchiectasi
air
bronchogram
n
ct
time
diagnosi
show
multifoc
peripher
subpleur
groundglass
opac
consolid
n
pneumomediastinum
seen
later
diseas
prognosi
therapi
n
support
respiratori
intens
care
therapi
n
inconclus
studi
regard
efficaci
antivir
n
specif
antibiot
therapi
case
secondari
bacteri
infect
n
prevent
nosocomi
transmiss
import
strategi
manag
case
hospit
set
fatal
case
sar
lung
usual
heavi
edemat
vari
degre
red
gray
hepat
multipl
bilater
hemorrhag
infarct
commonli
seen
associ
subpleur
hemorrhag
autopsi
result
report
singl
case
fatal
mer
infect
case
gross
examin
reveal
abund
pleural
effus
signific
pericardi
abdomin
effus
edemat
consolid
pulmonari
parenchyma
congest
main
histopatholog
pattern
diffus
alveolar
damag
fig
b
increas
mononuclear
cell
infiltr
interstitium
seen
case
sar
fig
mix
inflamm
edema
note
within
septa
fatal
mer
case
find
identifi
patient
includ
focal
intraalveolar
hemorrhag
necrot
inflammatori
debri
small
airway
organ
pneumonia
well
type
ii
pneumocyt
hyperplasia
intraalveolar
fibrin
necrosi
alveoli
submucos
gland
conduct
airway
fig
addit
multinucl
syncyti
cell
without
inclus
format
may
seen
alveolar
space
fatal
sar
case
patient
die
day
onset
ill
also
note
pulmonari
tissu
mer
fatal
fig
ish
ihc
studi
tissu
sar
patient
identifi
coronaviru
ciliat
columnar
epitheli
cell
trachea
bronchi
bronchiol
fig
pneumocyt
fig
occasion
macrophag
patient
antigen
readili
identifi
patient
die
within
first
week
onset
ill
mer
immunoreact
seen
pneumocyt
multinucl
syncyti
cell
necrot
histolog
unremark
bronchial
submucos
gland
fig
electron
microscop
examin
show
coronaviru
particl
cytoplasm
membranebound
vesicl
virus
fig
sar
particl
nucleocapsid
inclus
also
along
cell
membran
pneumocyt
phagosom
macrophag
associ
fibrin
alveolar
space
neg
stain
reveal
particl
averag
nm
size
characterist
crownlik
fring
surfac
fig
histopatholog
find
seen
lung
patient
die
mer
sar
somewhat
nonspecif
also
seen
acut
lung
injuri
case
caus
infecti
agent
trauma
drug
toxic
chemic
multinucl
syncyti
cell
also
found
mani
viral
infect
includ
measl
parainfluenza
virus
rsv
nipah
viru
infect
unequivoc
diagnosi
made
laboratori
test
viral
cultur
direct
fluoresc
antibodi
serolog
pcr
ihc
n
cytomegaloviru
cmv
larg
doublestrand
dna
viru
ubiquit
human
pathogen
north
america
infect
approxim
popul
like
herpesvirus
cmv
remain
host
life
primari
infect
establish
latenc
variou
cell
type
includ
vascular
endotheli
cell
monocyt
macrophag
neutrophil
renal
pulmonari
epitheli
cell
activ
viral
replic
occur
person
sever
compromis
immun
cmv
infect
inappar
although
case
primari
infect
otherwis
healthi
individu
result
selflimit
mononucleosi
syndrom
resembl
ill
caus
epsteinbarr
viru
pulmonari
involv
cmv
mononucleosi
occur
approxim
case
adult
children
advanc
hiv
diseas
recipi
hematopoiet
stem
cell
lung
transplant
inflammatori
bowel
diseas
increas
risk
develop
cmv
pneumonia
use
cmv
screen
effect
antivir
prophylaxi
regimen
patient
undergo
allogen
bone
marrow
transplant
leukemia
solid
organ
transplant
develop
cmv
pneumonia
casefat
rate
greater
seri
neonat
also
risk
symptomatolog
includ
fever
dyspnea
cough
rale
hypoxemia
system
dissemin
extrapulmonari
involv
occur
patient
pulmonari
cmv
diseas
typic
appear
bilater
nodular
reticular
opac
chest
radiograph
pleural
effus
identifi
approxim
patient
patient
may
coinfect
pulmonari
pathogen
radiolog
find
may
confus
patient
document
infect
normal
radiograph
ct
studi
sever
gener
pattern
pulmonari
cmv
infect
lung
typic
heavi
may
appear
diffus
consolid
show
scatter
nodular
foci
hemorrhag
necrosi
rare
cmv
infect
lung
manifest
singl
pulmonari
nodul
multipl
histopatholog
pattern
report
cmv
pneumonia
extens
intraalveolar
hemorrhag
scatter
cytomegal
cell
rel
scant
inflammatori
cell
infiltr
may
occur
similar
manner
extens
involv
alveolar
epithelium
minim
inflamm
overt
evid
parenchym
injuri
also
describ
pattern
includ
multifoc
miliari
lesion
mix
inflammatori
cell
infiltr
hemorrhag
necrosi
cytomegal
cell
diffus
predominantli
mononuclear
cell
infiltr
interstiti
pneumon
intraalveolar
edema
fibrin
deposit
diffus
distribut
cytomegal
cell
cytomegal
chang
cmvinfect
cell
evid
standard
hematoxylineosin
stain
virtual
pathognomon
activ
cmv
infect
cell
enlarg
micron
contain
amphophil
deepli
basophil
intranuclear
intracytoplasm
inclus
fig
singl
intranuclear
inclus
compos
viral
nucleoprotein
assembl
capsid
larg
micron
roundtoovoid
bodi
smoothli
contour
border
gener
surround
clear
halo
give
inclus
distinct
owl
eye
appear
ancillari
studi
cmv
pneumonia
defin
presenc
sign
symptom
pulmonari
diseas
combin
detect
cmv
bronchoalveolar
lavag
bal
fluid
lung
tissu
sampl
detect
method
support
definit
includ
viru
isol
histopatholog
observ
cytomegal
cell
ish
ihc
stain
fig
detect
pcr
alon
consid
sensit
diagnosi
cmv
pneumonia
insuffici
purpos
cmv
often
cultur
human
diploid
fibroblast
use
shell
vial
method
enhanc
infect
usual
yield
diagnost
result
within
hour
electron
microscop
examin
show
slightli
pleomorph
spheric
particl
without
nuclear
core
rang
nm
fig
histopatholog
featur
cmv
pneumonia
vari
differenti
diagnosi
depend
predomin
pattern
histolog
pattern
hemorrhag
miliari
inflammatori
lesion
diffus
interstiti
pneumon
cytopatholog
chang
cmvinfect
cell
gener
suffici
establish
diagnosi
cmv
inclus
may
occas
howev
confus
herpesvirus
adenovirus
measl
none
pathogen
collect
show
cytomegalya
singl
larg
nuclear
inclus
promin
haloand
multipl
small
cytoplasm
inclus
reactiv
pneumocyt
occasion
show
enlarg
nuclei
nuclei
immunoneg
ihc
cmv
ganciclovir
valganciclovir
foscarnet
cidofovir
intraven
cmv
immun
globulin
remain
import
line
treatment
cmv
pneumonia
diminish
mortal
immunosuppress
patient
diseas
nonetheless
mortal
attribut
cmv
pneumonia
approxim
candid
vaccin
develop
none
avail
typic
clinic
use
sever
viral
mutat
identifi
link
drug
resist
human
hsv
larg
envelop
doublestrand
dna
virus
approxim
nm
diamet
two
serolog
type
recogn
frequent
associ
particular
diseas
syndrom
howev
either
serotyp
may
caus
associ
clinic
syndrom
caus
gingivostomat
pharyng
esophag
keratoconjunct
enceph
serotyp
commonli
associ
adult
hsv
pneumonia
typic
infect
genit
site
serotyp
associ
approxim
dissemin
diseas
pulmonari
infect
newborn
infant
hsv
like
herpesvirus
abil
persist
inact
state
vari
period
recur
spontan
undefin
stimuli
associ
physic
emot
stress
trauma
nerv
root
ganglia
fever
immunosuppress
exposur
ultraviolet
radiat
tracheobronch
pneumonia
primari
respiratori
tract
manifest
hsv
infect
adult
infect
respiratori
tract
hsv
may
associ
dissemin
herpet
infect
commonli
identifi
isol
diseas
manifest
result
reactiv
latent
herpet
infect
oropharynx
mucocutan
herpet
infect
gener
preced
hsv
pneumonia
aspir
viruscontain
secret
lower
respiratori
tract
believ
frequent
caus
pulmonari
infect
hsv
howev
oral
lesion
may
absent
patient
herpet
laryngotrach
bronchopneumonia
diseas
also
associ
adult
infect
respiratori
tract
hsv
may
associ
dissemin
herpet
infect
commonli
identifi
isol
diseas
manifest
result
reactiv
latent
herpet
infect
oropharynx
n
dissemin
diseas
develop
approxim
infect
neonat
approxim
patient
develop
pneumonia
n
infant
dissemin
neonat
hsv
infect
first
show
sign
symptom
mean
day
birth
rang
day
diseas
progress
clinic
pictur
often
resembl
bacteri
sepsi
evolv
rapidli
pneumonia
shock
dissemin
vascular
coagulopathi
n
illdefin
nodular
reticular
densiti
variou
size
scatter
lung
field
n
earli
stage
diseas
nodul
measur
mm
best
seen
peripheri
lung
diseas
progress
lesion
coalesc
enlarg
form
extens
segment
subsegment
infiltr
n
pleural
effus
commonli
identifi
n
ct
studi
show
patchi
diffus
opac
multifoc
peribronchi
consolid
mixtur
pattern
therapi
n
antivir
therapi
includ
acyclovir
valacyclovir
famciclovir
n
foscarnet
use
effect
acyclovirresist
patient
airway
trauma
caus
tracheal
intub
hematogen
dissemin
hsv
newborn
infant
sever
immunosuppress
burn
patient
patient
sever
trauma
greatest
risk
develop
hsv
pneumonia
lower
respiratori
tract
diseas
neonat
commonli
associ
dissemin
herpet
infect
case
neonat
diseas
repres
primari
hsv
infect
acquir
parturit
hsvinfect
mother
incid
neonat
hsv
infect
approxim
deliveri
dissemin
diseas
develop
approxim
infect
neonat
dissemin
infect
sign
symptom
appear
mean
day
birth
rang
day
approxim
patient
develop
pneumonia
chest
radiograph
patient
hsv
pneumonia
show
illdefin
nodular
reticular
densiti
variou
size
scatter
lung
field
earli
stage
diseas
nodul
measur
mm
best
seen
peripheri
lung
diseas
progress
lesion
coalesc
enlarg
form
extens
segment
subsegment
infiltr
ct
show
patchi
diffus
area
groundglass
opac
multifoc
peribronchi
consolid
mixtur
pattern
pleural
effus
common
gross
find
hsv
tracheobronch
appear
ulcer
cover
fibrinopurul
exud
mucou
membran
hsv
pneumonia
acquir
airway
lung
heavi
show
nodular
hemorrhag
foci
gener
distribut
around
bronchi
bronchiol
hematogen
acquir
hsv
pneumonia
hemorrhag
foci
usual
random
miliari
distribut
herpet
tracheobronch
ulcer
process
character
larg
area
denud
mucos
epithelium
fibrinopurul
exud
contain
necrot
cell
despit
extens
tissu
damag
cell
intranuclear
inclus
may
spars
found
often
margin
ulcer
epithelium
occasion
mucou
gland
ulcer
mucosa
lung
herpet
lesion
show
extens
necrosi
karyorrhect
debri
associ
hemorrhag
sparsetomoder
neutrophil
infiltr
fig
b
intranuclear
inclus
best
appreci
cell
lead
edg
necrot
foci
inclus
appear
either
homogen
amphophil
glassi
typic
cowdri
type
b
inclus
eosinophil
halo
separ
inclus
nuclear
membran
typic
cowdri
type
inclus
fig
chang
associ
hsv
includ
multinucl
nuclear
mold
groundglass
nuclear
chromatin
balloon
degener
cytoplasm
fig
frequent
associ
squamou
epithelium
less
often
encount
lung
viru
isol
remain
import
diagnost
method
howev
hsv
isol
oropharyng
secret
occasion
lower
respiratori
tract
patient
lack
overt
pulmonari
diseas
virolog
cultur
must
interpret
context
complementari
clinic
radiograph
histopatholog
find
much
possibl
pcr
method
amplifi
hsv
dna
clinic
specimen
includ
tissu
blood
particularli
use
distinguish
infect
commerci
avail
antibodi
exist
ihc
detect
hsv
tissu
fig
e
electron
microscopi
also
use
demonstr
encapsul
viral
particl
targetoid
appear
arrang
latticelik
pattern
fig
hsv
vzv
adenovirus
measl
viru
cmv
caus
necrot
hemorrhag
pneumonia
produc
intranuclear
inclus
may
difficult
differenti
viral
inclus
hsv
ident
vzv
separ
accomplish
ihc
molecular
method
cultur
presenc
smudg
cell
support
diagnosi
adenoviru
hsv
produc
cytoplasm
inclus
seen
cmv
measl
discoveri
use
antivir
therapi
neonat
dissemin
hsv
diseas
die
infect
earli
diagnosi
highdos
acyclovir
therapi
howev
mortal
reduc
approxim
acyclovir
treatment
choic
foscarnet
use
effect
acyclovirresist
patient
concomit
bacteri
pneumonia
common
vzv
doublestrand
dna
human
alpha
herpesviru
close
relat
hsv
primari
infect
caus
varicella
chickenpox
reactiv
latent
viru
caus
herp
zoster
shingl
vzv
ubiquit
human
popul
around
world
human
known
natur
reservoir
prevaccin
era
unit
state
approxim
million
case
hospit
death
report
annual
vzvrelat
death
declin
sharpli
unit
state
howev
sinc
univers
childhood
vaccin
implement
primari
infect
vzv
occur
inocul
respiratori
mucosa
infecti
aerosol
direct
contact
skin
lesion
patient
varicella
herp
zoster
prurit
vesicular
rash
chickenpox
develop
incub
period
day
attack
rate
previous
uninfect
household
contact
expos
varicella
approxim
vzv
also
establish
latent
infect
within
satellit
cell
neuron
trigemin
dorsal
root
ganglia
reactiv
variou
condit
caus
herp
zoster
pain
unilater
vesicular
erupt
distribut
dermatom
distribut
although
chickenpox
usual
rel
benign
infect
children
adult
patient
approxim
time
like
children
develop
pneumonia
pneumonia
occur
approxim
adult
primarili
infect
vzv
howev
incid
pneumonia
bone
marrow
transplant
recipi
acut
leukemia
patient
may
high
greatest
risk
sever
diseas
pneumonia
occur
patient
chronic
lung
diseas
immunesuppress
condit
neonat
pregnant
women
occurr
pneumonia
herp
zoster
rare
limit
primarili
profoundli
immunosuppress
patient
particularli
bone
marrow
transplant
recipi
vzv
pneumonia
develop
day
onset
rash
character
fever
cough
tachypnea
chest
pain
hemoptysi
massiv
pulmonari
hemorrhag
pulmonari
infarct
frequent
termin
event
hematopoiet
cell
transplant
recipi
may
present
sign
viscer
dissemin
pneumonia
day
local
cutan
erupt
herp
zoster
appear
lower
respiratori
tract
diseas
describ
absenc
skin
lesion
particularli
neonat
bone
marrow
transplant
recipi
lung
show
multifoc
bilater
poorli
defin
nodular
densiti
measur
mm
greatest
dimens
opac
may
coalesc
form
extens
area
consolid
hilar
adenopathi
may
also
occur
pleural
effus
uncommon
patient
surviv
vzv
pneumonia
show
persist
parenchym
nodul
may
miner
persist
small
mm
calcif
predominantli
lower
zone
lung
lung
patient
fatal
vzv
pneumonia
two
three
time
heavier
normal
firm
plum
color
often
multipl
necrot
hemorrhag
lesion
viscer
pariet
pleura
resembl
pox
lesion
skin
trachea
bronchi
gener
edemat
erythemat
occasion
vesicl
mucos
surfac
may
lobular
consolid
lung
well
randomli
distribut
hemorrhag
lesion
lung
show
interstiti
pneumon
diffus
miliari
foci
necrosi
hemorrhag
pulmonari
parenchyma
involv
alveolar
wall
blood
vessel
bronchiol
fig
b
find
includ
intraalveolar
collect
edema
fibrin
hemorrhag
diffus
alveolar
damag
septal
edema
viral
infect
cell
intranuclear
inclus
may
identifi
respiratori
epitheli
cell
trachea
bronchi
pneumocyt
interstiti
fibroblast
capillari
endothelium
eosinophil
intranuclear
inclus
multinucl
syncyti
cell
may
difficult
locat
best
identifi
edg
necrot
foci
fig
case
dissemin
diseas
similar
necrot
hemorrhag
lesion
occasion
viral
cytopath
chang
epitheli
cell
fibroblast
may
observ
mani
tissu
organ
pulmonari
symptom
often
occur
sever
day
onset
characterist
rash
varicella
patholog
diagnosi
seldom
requir
realtim
diagnosi
vzv
pneumonia
antigen
detect
kit
use
fluoresceinconjug
vzv
monoclon
antibodi
help
rapid
diagnosi
cutan
vzv
infect
antibodi
also
commerci
avail
ihc
detect
vzv
tissu
specimen
fig
commerci
laboratori
offer
pcr
amplif
detect
viral
nucleic
acid
clinic
specimen
isol
viru
cell
cultur
remain
refer
standard
diagnosi
vzv
infecti
vzv
usual
recover
clear
fluid
cutan
vesicl
varicella
approxim
day
appear
lesion
approxim
week
herp
zoster
lesion
electron
microscopi
vzv
icosahedr
nucleocapsid
indistinguish
appear
herpesvirus
envelop
viral
particl
pleomorph
spheric
shape
nm
diamet
histopatholog
appear
vzv
pneumonia
close
resembl
diseas
caus
hsv
respect
gener
pattern
lung
injuri
eg
multicentr
necrot
hemorrhag
lesion
appear
glassi
intranuclear
inclus
n
spread
primarili
cough
sneez
infect
person
n
typic
incub
period
day
n
uncompl
influenza
ill
character
abrupt
onset
fever
myalgia
headach
malais
nonproduct
cough
sore
throat
rhiniti
n
unilater
bilater
consolid
lung
n
rare
associ
pleural
effus
n
vaccin
import
prevent
strategi
n
support
therapi
bed
rest
oral
hydrat
antipyret
n
antivir
oseltamivir
zanamivir
amantadin
may
help
earli
cours
infect
n
specif
antibiot
therapi
case
secondari
bacteri
infect
typic
incub
period
day
adult
infecti
day
symptom
begin
approxim
day
ill
onset
children
infecti
day
young
children
shed
viru
sever
day
ill
onset
sever
immunocompromis
person
shed
viru
week
month
respiratori
ill
caus
influenza
difficult
distinguish
ill
caus
respiratori
pathogen
basi
symptom
alon
uncompl
influenza
ill
character
abrupt
onset
constitut
respiratori
sign
symptom
includ
fever
myalgia
headach
malais
nonproduct
cough
sore
throat
rhiniti
among
children
otiti
media
nausea
vomit
also
commonli
report
influenza
typic
resolv
day
patient
although
cough
malais
persist
week
pandem
result
ill
rang
mild
sever
fatal
death
estim
million
case
unit
state
complic
includ
secondari
bacteri
pneumonia
febril
seizur
uncommonli
encephalopathi
transvers
myeliti
rey
syndrom
myositi
myocard
pericard
risk
complic
hospit
death
influenza
higher
among
person
age
year
older
young
children
person
age
certain
underli
health
condit
among
healthi
older
children
younger
adult
main
find
includ
unilater
bilater
patchi
consolid
lung
may
progress
confluent
lung
diseas
pleural
effus
uncommon
lung
influenza
viru
pneumonia
associ
bacteri
infect
differ
degre
hemorrhag
edema
airway
fill
vari
amount
exud
mucosa
trachea
larg
bronchi
hyperem
swollen
crosssect
lung
show
less
granular
appear
lower
lobe
affect
upper
lobe
gross
patholog
featur
secondari
infect
depend
larg
specif
microbi
usual
bacteri
pathogen
involv
mucosa
larg
airway
demonstr
hyperemia
hemorrhag
purul
necrot
debri
lung
extent
patholog
process
lower
lobe
gener
greater
upper
may
includ
consolid
abscess
hemorrhag
empyema
secondari
inflamm
region
lymph
node
may
present
purul
mediastin
pericard
may
also
found
case
histopatholog
featur
nonfat
fatal
influenza
includ
necrot
bronchiti
diffus
alveolar
damag
hemorrhag
edema
thrombi
patholog
promin
larger
bronchi
inflamm
may
vari
intens
fig
viral
inclus
identifi
light
microscopi
fig
secondari
bacteri
infect
organ
streptococcu
pneumonia
group
streptococcu
aureu
haemophilu
influenza
may
occur
complic
fatal
case
make
difficult
recogn
patholog
chang
associ
primari
viral
infect
fig
histopatholog
featur
organ
may
includ
myocard
cerebr
edema
rhabdomyolysi
hemophagocytosi
fig
b
unlik
mammalian
influenza
virus
avian
viru
preferenti
infect
cell
lower
respiratori
tract
human
result
extens
damag
lung
minim
patholog
upper
respiratori
tract
fig
may
explain
avian
influenza
viru
lethal
human
difficult
spread
person
person
studi
show
avian
viru
preferenti
bind
galactos
receptor
found
around
alveoli
contrast
mammalian
influenza
virus
preferenti
bind
receptor
found
throughout
respiratori
tract
nose
lung
absenc
characterist
viral
inclus
overal
patholog
featur
influenza
may
resembl
viral
rickettsi
certain
bacteri
infect
unequivoc
diagnosi
made
laboratori
test
viral
cultur
direct
fluoresc
antibodi
rapid
antigen
assay
serolog
ihc
ish
ihc
ish
assay
demonstr
viral
antigen
nucleic
acid
epitheli
cell
small
airway
fig
type
ii
pneumocyt
gland
larg
conduct
airway
fig
f
antigen
readili
identifi
patient
die
within
day
onset
ill
vaccin
import
strategi
prevent
influenza
viru
infect
season
influenza
seldom
fatal
immunocompet
host
recoveri
usual
complet
support
manag
bed
rest
hydrat
antipyret
basi
treatment
antivir
agent
may
help
earli
cours
ill
na
major
antigen
determin
influenza
virus
catalyz
cleavag
glycosid
linkag
sialic
acid
releas
progeni
virion
infect
measl
viru
highli
contagi
spread
aerosol
droplet
respiratori
secret
acut
case
children
usual
infect
year
age
result
lifelong
immun
almost
adult
immun
either
vaccin
exposur
clinic
infect
children
younger
month
age
gener
uncommon
passiv
protect
afford
infant
transfer
matern
antibodi
although
occasion
infect
occur
age
group
person
acut
measl
infect
onset
symptom
end
fever
incub
period
week
prodrom
phase
measl
begin
fever
rhinorrhea
cough
conjunct
koplik
spot
small
irregular
red
spot
bluishwhit
speck
center
appear
buccal
mucosa
case
shortli
rash
onset
erythemat
maculopapular
rash
begin
face
day
prodrom
symptom
usual
spread
trunk
extrem
symptom
gradual
resolv
rash
last
approxim
day
fade
order
appear
chest
radiograph
typic
show
fine
reticular
groundglass
opac
well
nodul
patchi
consolid
bronchial
thicken
peribronchi
opac
may
also
observ
patient
pleural
effus
rare
fatal
case
lung
heavi
show
congest
hemorrhag
edema
gross
patholog
featur
gender
race
age
distribut
n
infect
children
younger
month
age
uncommon
passiv
protect
immun
mother
n
children
nonvaccin
usual
infect
year
age
n
natur
infect
result
lifelong
immun
almost
adult
immun
either
due
exposur
vaccin
n
recogn
gender
racial
predilect
clinic
featur
n
typic
incub
period
week
n
brief
prodrom
character
fever
rhinorrhea
cough
conjunct
n
koplik
spot
seen
buccal
mucosa
shortli
rash
onset
n
erythemat
maculopapular
rash
begin
face
day
prodrom
symptom
usual
spread
trunk
extrem
n
rash
last
approxim
day
fade
order
appear
n
fine
reticular
groundglass
opac
lung
n
nodul
patchi
consolid
throughout
lung
may
seen
n
rare
associ
pleural
effus
prognosi
therapi
n
recoveri
rapid
complet
case
n
support
therapi
administ
bed
rest
oral
hydrat
antipyret
n
immun
globulin
use
treatment
given
earli
infect
n
vaccin
also
help
given
within
day
exposur
secondari
infect
depend
larg
specif
microbi
usual
bacteri
pathogen
involv
focal
gener
interstiti
pneumon
similar
seen
mani
viral
infect
seen
lung
measl
patient
histopatholog
featur
includ
variou
degre
peribronchi
interstiti
mononuclear
cell
infiltr
squamou
metaplasia
bronchial
endothelium
prolifer
type
ii
pneumocyt
intraalveolar
edema
without
mononuclear
cell
exud
hyalin
membran
secondari
chang
creat
bacteri
viral
superinfect
organiz
chang
may
alter
origin
patholog
hallmark
diseas
format
multinucl
epitheli
giant
cell
cell
often
numer
form
fusion
bronchiolar
alveolar
line
cell
fig
cell
gener
contain
characterist
nuclear
cytoplasm
inclus
intranuclear
inclus
homogen
eosinophil
surround
slight
indistinct
halo
fig
cytoplasm
inclus
deepli
eosinophil
may
form
larg
mass
melt
tallow
appear
fig
giant
cell
may
undergo
degen
chang
progress
loss
cytoplasm
increas
basophilia
shrinkag
nuclei
presenc
measl
viru
giant
cell
may
demonstr
immunofluoresc
ihc
ish
techniqu
fig
giant
cell
also
seen
extrapulmonari
tissu
laboratori
confirm
use
avoid
possibl
confus
rashcaus
ill
diagnost
laboratori
procedur
consist
either
direct
detect
viru
viral
antigen
usual
indirect
immunofluoresc
serolog
method
use
hemagglutin
inhibit
neutral
eia
specimen
serolog
test
consist
acuteand
convalescentphas
serum
pair
presenc
specif
igm
antibodi
use
diagnos
recent
infect
ihc
ish
perform
tissu
specimen
ultrastructur
measl
virion
pleomorph
gener
spheric
envelop
particl
nm
diamet
lipid
envelop
surround
helic
nucleocapsid
compos
rna
protein
typic
case
diagnosi
measl
usual
made
basi
clinic
sign
symptom
caus
similar
rash
without
featur
measl
includ
rubella
dengu
viru
enterovirus
ev
drug
reaction
especi
ampicillin
histolog
diagnosi
facilit
identif
characterist
giant
cell
set
interstiti
pneumon
giant
cell
seen
case
measl
pneumonia
howev
absenc
exclud
diagnosi
furthermor
viral
pathogen
rsv
parainfluenza
metapneumoviru
vzv
recent
discov
henipavirus
may
also
give
rise
pneumonia
giant
cell
consid
differenti
diagnosi
ihc
ish
test
demonstr
viral
antigen
nucleic
acid
major
case
assist
histolog
diagnosi
support
therapi
bed
rest
oral
hydrat
antipyret
usual
produc
rapid
complet
recoveri
immun
globulin
use
treatment
given
earli
infect
vaccin
also
help
treatment
regimen
given
within
day
exposur
smaller
number
patient
complic
aris
result
continu
progress
viru
replic
bacteri
viral
superinfect
abnorm
host
immun
respons
common
complic
secondari
bacteri
pneumonia
otiti
media
set
specif
antibiot
therapi
administ
complic
includ
febril
convuls
enceph
liver
function
abnorm
chronic
hpiv
spread
respiratori
secret
close
contact
infect
person
contact
contamin
surfac
object
infect
occur
infecti
materi
contact
mucou
membran
eye
mouth
nose
possibl
inhal
droplet
gener
sneez
cough
hpiv
ubiquit
infect
peopl
childhood
serolog
survey
shown
children
age
year
older
antibodi
antibodi
differ
hpiv
serotyp
differ
clinic
present
frequent
associ
outbreak
croup
often
associ
bronchiol
pneumonia
infrequ
detect
possibl
less
like
caus
sever
diseas
incub
period
gener
day
hpiv
also
caus
repeat
infect
throughout
life
usual
manifest
upper
respiratori
tract
ill
cold
sore
throat
seriou
lower
respiratori
tract
diseas
eg
pneumonia
bronchiti
bronchiol
also
occur
repeat
infect
especi
among
elderli
among
patient
compromis
immun
nosocomi
acquisit
occur
high
rate
hospit
set
thu
strict
prevent
control
measur
advis
main
find
associ
hpiv
pneumonia
includ
diffus
interstiti
opac
bronchial
wall
thicken
peribronchi
consolid
infect
rare
associ
pleural
effus
fatal
case
lung
typic
heavi
display
congest
hemorrhag
edema
patient
sever
hpiv
infect
multinucl
giant
cell
deriv
respiratori
epithelium
may
seen
associ
interstiti
pneumon
diffus
croup
typic
incub
period
day
n
less
commonli
present
symptom
lower
respiratori
ill
pneumonia
bronchiti
bronchiol
elderli
immunosuppress
patient
n
interstiti
opac
bronchial
wall
thicken
peribronchi
consolid
n
rare
associ
pleural
effus
prognosi
therapi
n
recoveri
rapid
complet
case
n
support
manag
bed
rest
oral
hydrat
antipyret
n
aerosol
ribavirin
use
immunosuppress
patient
sever
ill
alveolar
damag
bronchiol
organ
chang
fig
giant
cell
may
contain
intracytoplasm
eosinophil
inclus
fig
also
report
extrapulmonari
tissu
kidney
bladder
pancrea
diagnosi
infect
hpiv
made
viru
isol
direct
detect
viral
antigen
eia
indirect
fluoresc
antibodi
ifa
clinic
specimen
detect
viral
rna
rtpcr
demonstr
rise
specif
serum
antibodi
combin
approach
hpiv
infect
lung
confirm
ihc
test
formalinfix
tissu
fig
e
viral
antigen
detect
giant
cell
pneumocyt
respiratori
epitheli
cell
ultrastructur
studi
demonstr
variabl
shape
virion
vari
size
rang
nm
lipid
envelop
surround
helic
nucleocapsid
compos
rna
protein
fig
viral
caus
giant
cell
pneumonia
includ
measl
rsv
consid
histopatholog
differenti
diagnosi
laboratori
test
includ
ihc
use
determin
correct
diagnosi
hpiv
infect
caus
mild
selflimit
ill
highest
rate
seriou
hpiv
ill
occur
among
young
children
hpiv
infect
also
increasingli
recogn
import
caus
sever
morbid
mortal
immunocompromis
adult
mortal
bone
marrow
transplant
patient
infect
report
high
support
manag
bed
rest
oral
hydrat
antipyret
basi
treatment
aerosol
ribavirin
shown
efficaci
treatment
sever
case
hpiv
infect
approv
vaccin
hpiv
though
sever
vaccin
evalu
clinic
trial
rsv
negativesens
nonseg
singlestrand
envelop
rna
viru
rsv
member
famili
paramyxovirida
distinguish
genet
antigen
two
subgroup
b
subgroup
strain
usual
associ
sever
infect
rsv
common
caus
bronchiol
pneumonia
among
infant
children
year
age
temper
climat
rsv
infect
usual
occur
annual
commun
outbreak
often
last
sever
month
late
fall
winter
earli
spring
month
time
sever
outbreak
commun
vari
year
year
rsv
spread
effici
annual
outbreak
infect
mani
children
first
year
life
children
serolog
evid
rsv
infect
year
age
ill
begin
frequent
fever
runni
nose
cough
sometim
wheez
first
rsv
infect
infant
young
children
sign
symptom
bronchiol
pneumonia
requir
hospit
major
children
hospit
rsv
infect
less
month
age
children
cyanot
congenit
heart
diseas
cystic
fibrosi
bronchopulmonari
dysplasia
immunosuppress
rsv
also
caus
repeat
infect
throughout
life
sever
lower
respiratori
tract
diseas
may
occur
age
especi
among
elderli
among
compromis
cardiac
pulmonari
immun
system
children
rsv
infect
commonli
show
multifoc
airspac
consolid
peribronchi
thicken
adult
diseas
character
bilater
interstiti
opac
multifoc
consolid
larg
small
airway
contain
necrot
debri
mucu
may
show
ulcer
lung
may
heavi
diffus
firm
may
show
area
hyperexpans
atelectasi
major
histopatholog
chang
describ
fatal
rsv
infect
necrot
bronchiol
interstiti
pneumonia
bronchiolar
lumen
airway
usual
fill
necrot
debri
inflammatori
cell
fig
airway
show
mix
predominantli
mononuclear
infiltr
hyperplast
epitheli
chang
fig
find
may
accompani
diffus
alveolar
damag
secondari
bacteri
superinfect
giant
cell
pneumonia
seen
case
fig
multinucl
giant
cell
repres
epitheli
cell
bronchi
bronchiol
alveoli
sometim
contain
irregular
intracytoplasm
eosinophil
inclus
surround
clear
halo
fig
diagnosi
rsv
infect
made
viru
isol
direct
detect
viral
antigen
clinic
specimen
eia
ifa
ihc
fig
f
detect
viral
rna
rtpcr
demonstr
rise
rsvspecif
serum
antibodi
viru
labil
attempt
cultur
isol
often
unsuccess
delay
mishandl
clinic
specimen
ultrastructur
studi
reveal
virion
variabl
shape
respiratori
syncyti
viru
pneumoniafact
sheet
definit
n
rsv
negativesens
nonseg
singlestrand
envelop
rna
viru
member
famili
paramyxovirida
incid
locat
n
worldwid
distribut
n
rsv
spread
effici
among
children
annual
outbreak
infect
mani
children
first
year
life
n
children
serolog
evid
rsv
infect
year
age
n
estim
infant
young
children
infect
rsv
hospit
n
children
hospit
rsv
infect
month
age
cyanot
congenit
heart
diseas
cystic
fibrosi
bronchopulmonari
dysplasia
immunosuppress
mortal
n
mortal
otherwis
healthi
children
hospit
rsv
pneumonia
less
n
rsv
pneumonia
fatal
mani
patient
immun
suppress
underli
diseas
n
mortal
greatest
infant
congenit
heart
diseas
associ
pulmonari
hypertens
approach
gender
race
age
distribut
n
rsv
common
caus
bronchiol
pneumonia
among
infant
children
less
year
age
n
recogn
gender
racial
predilect
clinic
featur
n
fever
runni
nose
cough
sometim
wheez
n
first
rsv
infect
infant
young
children
sign
symptom
bronchiol
pneumonia
n
rsv
caus
repeat
infect
throughout
life
usual
associ
moderatetosever
coldlik
symptom
n
sever
lower
respiratori
tract
diseas
may
occur
age
especi
among
elderli
among
compromis
cardiac
pulmonari
immun
system
primarili
parainfluenza
virus
measl
virus
n
herp
simplex
vzv
rare
produc
multinucl
cytolog
chang
lung
n
confirm
diagnosi
clinic
laboratori
test
ihc
size
rang
nm
numer
glycoprotein
spike
viral
caus
giant
cell
pneumonia
consid
histopatholog
differenti
diagnosi
primarili
parainfluenza
virus
measl
virus
herp
simplex
vzv
less
commonli
produc
multinucl
giant
cell
lung
mortal
otherwis
healthi
children
hospit
rsv
pneumonia
less
howev
diseas
fatal
mani
patient
immun
hmpv
infect
ubiquit
occur
infanc
earli
childhood
annual
epidem
peak
occur
late
winter
spring
month
temper
region
often
overlap
part
whole
annual
rsv
epidem
seropreval
studi
reveal
children
age
month
antibodi
hmpv
age
year
patient
evid
past
infect
incub
period
gener
day
although
hmpv
associ
spectrum
respiratori
diseas
infect
caus
mild
selflimit
ill
though
sever
diseas
occur
particularli
immunocompromis
patient
patient
may
asymptomat
symptom
may
rang
mild
upper
respiratori
tract
ill
sever
bronchiol
pneumonia
hypotens
septic
shock
first
hmpv
infect
infant
young
children
sign
symptom
bronchiol
pneumonia
onehalf
case
lower
respiratori
ill
children
occur
first
month
life
suggest
young
age
major
risk
factor
sever
diseas
underli
pulmonari
diseas
especi
asthma
may
increas
risk
hospit
hmpv
pneumonia
persist
asymptomat
infect
report
radiograph
find
vari
includ
diffus
bilater
alveolar
infiltr
interstiti
infiltr
focal
consolid
commonli
involv
lower
lobe
lung
emphysema
without
infiltr
fatal
case
lung
typic
heavi
display
congest
hemorrhag
edema
definit
n
hmpv
negativesens
nonseg
singlestrand
envelop
rna
viru
member
famili
paramyxovirida
subfamili
pneumovirina
genu
metapneumoviru
n
hmpv
distinguish
genet
antigen
two
subgroup
b
incid
locat
n
worldwid
distribut
n
children
age
month
children
age
year
serolog
evid
hmpv
infect
n
annual
epidem
peak
occur
late
winter
spring
month
temper
region
often
overlap
part
whole
rsv
epidem
n
infant
hospit
acut
respiratori
ill
fever
associ
hmpv
major
children
hospit
hmpv
infect
month
age
children
underli
pulmonari
diseas
especi
asthma
n
may
also
contribut
sever
respiratori
diseas
elderli
immunocompromis
adult
mortal
n
mortal
otherwis
healthi
children
hospit
hmpv
pneumonia
less
n
diseas
may
fatal
mani
patient
immun
suppress
underli
diseas
histopatholog
descript
assess
valid
complic
uncertainti
case
clinic
signific
detect
ubiquit
viru
nonetheless
bal
specimen
collect
patient
within
day
posit
hmpv
assay
show
degen
chang
cytoplasm
inclus
within
epitheli
cell
multinucl
giant
cell
histiocyt
intracytoplasm
inclus
illdefin
eosinophil
structur
measur
histolog
chang
includ
necrot
bronchiol
diffus
alveolar
damag
hyalin
membran
format
chronic
airway
inflamm
intraalveolar
foami
hemosiderinladen
macrophag
alveolar
hemorrhag
acut
organ
lung
injuri
organ
pneumonia
fig
b
case
typic
multinucl
giant
cell
viral
inclus
identifi
ish
studi
limit
number
human
case
suggest
infect
alveolar
bronchial
epitheli
cell
hmpv
difficult
identifi
commonli
use
viral
diagnost
procedur
viru
replic
slowli
primari
tertiari
monkey
kidney
cell
line
cytopath
effect
difficult
discern
hmpv
studi
conduct
use
rtpcr
assay
demonstr
rise
hmpvspecif
serum
antibodi
ihc
ifa
assay
also
exist
fig
envelop
virion
variabl
shape
size
rang
nm
fig
viral
caus
giant
cell
pneumonia
diffus
alveolar
damag
includ
measl
rsv
hpiv
measl
vzv
hsv
may
consid
well
noninfecti
caus
diffus
alveolar
damag
laboratori
test
includ
ihc
ish
use
make
differenti
possibl
support
manag
bed
rest
oral
hydrat
antipyret
basi
treatment
usual
lead
complet
recoveri
licens
vaccin
therapi
prophylact
treatment
hmpv
time
ribavirin
intraven
immunoglobulin
activ
rsv
test
hmpv
vitro
found
equival
activ
hmpv
rsv
enteroviru
genu
within
famili
picornavirida
includ
ev
rv
nonenvelop
singlestrand
rna
virus
molecular
serolog
characterist
defin
virus
speci
contain
mani
type
seven
speci
human
pathogen
includ
four
ev
speci
eva
evb
evc
evd
three
rv
speci
rva
rvb
rvc
import
pathogen
ev
member
includ
sever
coxsackieviru
group
cva
virus
within
eva
coxsackieviru
group
b
cvb
virus
echovirus
within
evb
poliovirus
sever
cva
virus
within
evc
within
evd
ev
one
lead
caus
upper
respiratori
tract
infect
common
cold
associ
divers
clinic
syndrom
span
mild
ill
sever
potenti
fatal
condit
unit
state
evand
rvassoci
respiratori
infect
occur
radiograph
find
includ
perihilar
alveolar
infiltr
patchi
consolid
pneumothorax
atelectasi
extensivetopatchi
groundglass
opac
report
ct
scan
extens
gross
patholog
find
fatal
case
report
find
case
similar
case
viral
pneumonia
congest
hemorrhag
edema
hyperinfl
mucu
plug
also
note
similar
hmpv
histopatholog
descript
mononuclear
bronchiol
interstiti
pneumon
main
report
histolog
find
fig
bronchiol
obliteran
organ
pneumonia
acut
alveol
tracheobronch
also
report
comorbid
asthma
coinfect
viral
bacteri
pathogen
occur
histolog
chang
influenc
specif
agent
condit
diagnosi
made
viru
isol
ish
direct
detect
viral
antigen
ifa
ihc
fig
detect
viral
rna
pcr
assay
fresh
clinic
sampl
formalinfix
paraffinembed
tissu
demonstr
rise
serum
antibodi
serolog
regard
reliabl
diagnost
tool
pcr
often
reli
upon
definit
diagnosi
specif
viru
identif
systemat
studi
evalu
local
ev
antigen
tissu
sampl
need
one
experiment
inocul
studi
viral
nucleic
acid
note
within
bronchiolar
epithelium
ish
antigen
note
airway
epithelium
cell
within
alveoli
within
alveolar
macrophag
bronchiolar
gland
small
number
case
viral
caus
interstiti
pneumon
bronchiol
includ
rsv
hpiv
hmpv
influenza
viru
consid
laboratori
test
includ
pcr
ihc
use
make
differenti
possibl
therapi
n
treatment
support
includ
mechan
ventil
need
n
equivoc
data
regard
efficaci
ribavirin
treatment
symptom
fever
headach
vomit
alter
level
conscious
respiratori
ill
much
common
bangladesh
case
howev
cough
dyspnea
epidemiolog
laboratori
investig
identifi
pteropid
bat
asymptomat
carrier
hendra
nipah
virus
natur
anim
reservoir
foodborn
transmiss
also
report
individu
consum
fruit
contamin
pteropu
bat
patient
respiratori
ill
chest
radiograph
reveal
bilater
infiltr
consist
ard
fatal
infect
lung
heavi
congest
edemat
hemorrhag
histopatholog
find
fatal
case
hendra
nipah
infect
similar
vari
degre
central
nervou
system
respiratori
tract
involv
find
includ
system
vascul
extens
thrombosi
endotheli
cell
damag
necrosi
syncyti
giant
cell
format
affect
vessel
fig
multinucl
giant
cell
intranuclear
inclus
occasion
seen
lung
spleen
lymph
node
kidney
lung
vascul
fibrinoid
necrosi
seen
major
case
interstiti
pneumon
edema
congest
epitheli
syncyti
cell
seen
fig
multinucl
giant
cell
intranuclear
inclus
usual
note
alveolar
space
adjac
necrot
area
fig
diagnosi
nipah
viru
infect
suspect
patient
histori
clinic
manifest
support
characterist
histopatholog
find
uniqu
histopatholog
find
presenc
syncyti
parenchym
multinucl
endotheli
cell
howev
featur
occur
onefourth
case
use
sensit
criterion
diagnosi
henipaviru
infect
furthermor
similar
cell
also
seen
measl
viru
rsv
hpiv
herpesvirus
infect
addit
viral
infect
noninfecti
caus
diffus
alveolar
damag
may
consid
differenti
diagnosi
unequivoc
diagnosi
made
laboratori
test
ihc
cell
cultur
isol
pcr
serolog
ihc
reveal
widespread
presenc
nipah
viru
antigen
endotheli
smooth
muscl
cell
blood
vessel
well
variou
parenchym
cell
fig
ultrastructur
studi
also
demonstr
pleomorph
viral
particl
compos
helic
nucleocapsid
enclos
within
envelop
fig
seven
person
known
infect
hendra
viru
death
occur
patient
infect
nipah
viru
frequent
patient
rapidli
develop
sever
neurolog
sign
residu
neurolog
sign
common
among
survivor
treatment
support
includ
mechan
ventil
patient
deep
coma
unabl
maintain
airway
ribavirin
use
human
nipah
outbreak
malaysia
equivoc
result
passiv
immun
target
nipah
g
glycoprotein
evalu
postexposur
therapi
ferret
model
found
benefit
gross
find
n
fatal
case
lung
heavi
display
congest
hemorrhag
edema
n
histopatholog
involv
central
nervou
system
respiratori
system
n
vascul
thrombosi
endotheli
cell
damag
syncyti
cell
format
n
multinucl
giant
cell
intranuclear
cytoplasm
inclus
brain
lung
organ
n
organ
diffus
alveolar
damag
patient
die
later
cours
ill
first
describ
oldest
best
known
yellow
fever
viru
other
includ
lassa
fever
lymphocyt
choriomening
ebola
dengu
virus
distribut
individu
vhf
relat
distribut
specif
arthropod
rodent
vector
vhf
character
clinic
disproportion
effect
vascular
system
typic
manifest
relat
loss
vascular
regul
vasodilat
hypotens
vascular
damag
leakag
protein
urin
edema
soft
tissu
face
loos
connect
tissu
petechi
hemorrhag
skin
intern
organ
sever
system
derang
present
fever
myalgia
asthenia
proceed
state
prostrat
hemorrhag
common
diseas
usual
origin
mucos
surfac
patient
sever
hemorrhag
fever
gener
develop
shock
diffus
bleed
central
nervou
system
dysfunct
patient
respiratori
ill
chest
radiograph
may
reveal
bilater
interstiti
alveolar
edema
hemorrhag
fatal
vhf
lung
show
congest
hemorrhag
edema
pleural
effus
may
found
certain
infect
viral
hemorrhag
feversfact
sheet
definit
n
vhf
system
infect
character
fever
hemorrhag
caus
group
virus
transmit
human
arthropod
rodent
n
virus
belong
four
differ
famili
differ
genom
structur
replic
strategi
morpholog
featur
arenavirida
bunyavirida
flavivirida
filovirida
n
arenavirus
bunyavirus
filovirus
negativestrand
wherea
flavivirus
positivestrand
rna
virus
incid
locat
n
uncommon
diseas
n
hemorrhag
fever
virus
distribut
worldwid
diseas
caus
tradit
name
accord
locat
first
describ
n
distribut
particular
vhf
relat
distribut
specif
arthropod
rodent
bat
vector
ultrastructur
featur
n
featur
vari
four
famili
virus
caus
vhf
syndrom
n
virus
lipid
envelop
acquir
bud
either
cell
surfac
intern
membran
n
size
shape
virus
vari
rel
small
nm
uniform
round
particl
seen
flavivirus
pleomorph
rodshap
particl
occasion
measur
nm
case
filovirus
patholog
differenti
diagnosi
n
caus
hemorrhag
edema
diffus
alveolar
damag
n
unequivoc
diagnosi
made
laboratori
test
cell
cultur
isol
serolog
pcr
ihc
autopsi
common
find
includ
widespread
petechi
hemorrhag
ecchymos
involv
skin
mucou
membran
intern
organ
howev
mani
vhf
patient
manifest
bleed
may
minim
absent
effus
occasion
hemorrhag
also
frequent
seen
widespread
focal
sometim
massiv
necrosi
commonli
observ
organ
system
often
ischem
natur
necrosi
usual
promin
liver
lymphoid
tissu
consist
microscop
featur
found
liver
consist
multifoc
hepatocellular
necrosi
cytoplasm
eosinophilia
councilman
bodi
nuclear
pyknosi
cytolysi
inflammatori
cell
infiltr
necrot
area
usual
mild
present
consist
neutrophil
mononuclear
cell
commonli
observ
histopatholog
chang
lung
includ
variou
degre
hemorrhag
intraalveolar
edema
interstiti
pneumon
diffus
alveolar
damag
fig
e
diagnosi
vhf
suspect
patient
appropri
clinic
manifest
return
endem
area
particularli
travel
rural
area
season
epidem
diseas
activ
diagnosi
suspect
histori
clinic
manifest
also
support
histopatholog
howev
similar
patholog
featur
seen
vhf
varieti
viral
rickettsi
bacteri
infect
well
noninfecti
caus
hemorrhag
edema
diffus
alveolar
damag
unequivoc
diagnosi
made
laboratori
test
cell
cultur
isol
serolog
pcr
ihc
fig
c
f
ultrastructur
studi
also
demonstr
presenc
virion
virus
lipid
envelop
acquir
bud
either
cell
surfac
intern
membran
size
shape
virus
vari
rel
small
nm
uniform
round
particl
seen
flavivirus
pleomorph
rodshap
particl
measur
occasion
nm
case
filovirus
fig
case
mortal
rang
infect
lassa
fever
filoviru
infect
ebola
total
suspect
confirm
case
report
death
outbreak
ebola
west
africa
treatment
depend
particular
agent
may
includ
use
passiv
antibodi
antivir
drug
ribavirin
support
therapi
support
therapi
includ
reason
measur
would
employ
ill
patient
fragil
vascular
bed
volum
replac
may
particularli
import
patient
especi
dengu
hemorrhag
fever
experiment
vaccin
treatment
ebola
clinic
trial
gener
